Advanced Search
Display options
Filter resources
Text Availability
Article type
Publication date
Species
Language
Sex
Age
Showing 1 to 12 of 50 entries
Sorted by: Best Match Show Resources per page
Seroprevalence and comparison of different serological tests for brucellosis detection in small ruminants.

Veterinary world

Sadhu DB, Panchasara HH, Chauhan HC, Sutariya DR, Parmar VL, Prajapati HB.
PMID: 27047135
Vet World. 2015 May;8(5):561-6. doi: 10.14202/vetworld.2015.561-566. Epub 2015 May 04.

AIM: The aim was to study the seroprevalence and efficacy of the different serological tests used for detection of antibody against Brucella species in small ruminants of Banaskantha district of North-Gujarat.MATERIALS AND METHODS: Total 1000 serum samples comprising of...

Cite
Sadhu DB, Panchasara HH, Chauhan HC, et al. Seroprevalence and comparison of different serological tests for brucellosis detection in small ruminants. Vet World. 2015;8(5):561-6doi: 10.14202/vetworld.2015.561-566.
Sadhu, D. B., Panchasara, H. H., Chauhan, H. C., Sutariya, D. R., Parmar, V. L., & Prajapati, H. B. (2015). Seroprevalence and comparison of different serological tests for brucellosis detection in small ruminants. Veterinary world, 8(5), 561-6. https://doi.org/10.14202/vetworld.2015.561-566
Sadhu, Dashrath B, et al. "Seroprevalence and comparison of different serological tests for brucellosis detection in small ruminants." Veterinary world vol. 8,5 (2015): 561-6. doi: https://doi.org/10.14202/vetworld.2015.561-566
Sadhu DB, Panchasara HH, Chauhan HC, Sutariya DR, Parmar VL, Prajapati HB. Seroprevalence and comparison of different serological tests for brucellosis detection in small ruminants. Vet World. 2015 May;8(5):561-6. doi: 10.14202/vetworld.2015.561-566. Epub 2015 May 04. PMID: 27047135; PMCID: PMC4774713.
Copy Download .nbib Format: NLM
Engineering triiodothyronine (T3) nanoparticle for use in ischemic brain stroke.

Drug delivery and translational research

Mdzinarishvili A, Sutariya V, Talasila PK, Geldenhuys WJ, Sadana P.
PMID: 23864999
Drug Deliv Transl Res. 2013 Aug;3(4):309-17. doi: 10.1007/s13346-012-0117-8.

A potential means of pharmacological management of ischemic stroke is rapid intervention using potent neuroprotective agents. Thyroid hormone (T3) has been shown to protect against ischemic damage in middle cerebral artery occlusion (MCAO) model of ischemic brain stroke. While...

Cite
Mdzinarishvili A, Sutariya V, Talasila PK, et al. Engineering triiodothyronine (T3) nanoparticle for use in ischemic brain stroke. Drug Deliv Transl Res. 2013;3(4):309-17doi: 10.1007/s13346-012-0117-8.
Mdzinarishvili, A., Sutariya, V., Talasila, P. K., Geldenhuys, W. J., & Sadana, P. (2013). Engineering triiodothyronine (T3) nanoparticle for use in ischemic brain stroke. Drug delivery and translational research, 3(4), 309-17. https://doi.org/10.1007/s13346-012-0117-8
Mdzinarishvili, Alexander, et al. "Engineering triiodothyronine (T3) nanoparticle for use in ischemic brain stroke." Drug delivery and translational research vol. 3,4 (2013): 309-17. doi: https://doi.org/10.1007/s13346-012-0117-8
Mdzinarishvili A, Sutariya V, Talasila PK, Geldenhuys WJ, Sadana P. Engineering triiodothyronine (T3) nanoparticle for use in ischemic brain stroke. Drug Deliv Transl Res. 2013 Aug;3(4):309-17. doi: 10.1007/s13346-012-0117-8. PMID: 23864999; PMCID: PMC3693440.
Copy Download .nbib Format: NLM
Expression Profiling Identifies the Noncoding Processed Transcript of HNRNPU with Proliferative Properties in Pancreatic Ductal Adenocarcinoma.

Non-coding RNA

Sutaria DS, Jiang J, Azevedo-Pouly ACP, Lee EJ, Lerner MR, Brackett DJ, Vandesompele J, Mestdagh P, Schmittgen TD.
PMID: 29657295
Noncoding RNA. 2017 Aug 25;3(3). doi: 10.3390/ncrna3030024.

A gene array was used to profile the expression of 22,875 long non-coding RNAs (lncRNAs) and a large number of protein coding genes in 47 specimens of pancreatic ductal adenocarcinoma (PDAC), adjacent benign pancreas and the pancreas from patients...

Cite
Sutaria DS, Jiang J, Azevedo-Pouly ACP, et al. Expression Profiling Identifies the Noncoding Processed Transcript of HNRNPU with Proliferative Properties in Pancreatic Ductal Adenocarcinoma. Noncoding RNA. 2017;3(3)doi: 10.3390/ncrna3030024.
Sutaria, D. S., Jiang, J., Azevedo-Pouly, A. C. P., Lee, E. J., Lerner, M. R., Brackett, D. J., Vandesompele, J., Mestdagh, P., & Schmittgen, T. D. (2017). Expression Profiling Identifies the Noncoding Processed Transcript of HNRNPU with Proliferative Properties in Pancreatic Ductal Adenocarcinoma. Non-coding RNA, 3(3), . https://doi.org/10.3390/ncrna3030024
Sutaria, Dhruvitkumar S, et al. "Expression Profiling Identifies the Noncoding Processed Transcript of HNRNPU with Proliferative Properties in Pancreatic Ductal Adenocarcinoma." Non-coding RNA vol. 3,3 (2017). doi: https://doi.org/10.3390/ncrna3030024
Sutaria DS, Jiang J, Azevedo-Pouly ACP, Lee EJ, Lerner MR, Brackett DJ, Vandesompele J, Mestdagh P, Schmittgen TD. Expression Profiling Identifies the Noncoding Processed Transcript of HNRNPU with Proliferative Properties in Pancreatic Ductal Adenocarcinoma. Noncoding RNA. 2017 Aug 25;3(3). doi: 10.3390/ncrna3030024. PMID: 29657295; PMCID: PMC5831917.
Copy Download .nbib Format: NLM
Comprehensive toxicity and immunogenicity studies reveal minimal effects in mice following sustained dosing of extracellular vesicles derived from HEK293T cells.

Journal of extracellular vesicles

Zhu X, Badawi M, Pomeroy S, Sutaria DS, Xie Z, Baek A, Jiang J, Elgamal OA, Mo X, Perle K, Chalmers J, Schmittgen TD, Phelps MA.
PMID: 28717420
J Extracell Vesicles. 2017 Jun 06;6(1):1324730. doi: 10.1080/20013078.2017.1324730. eCollection 2017.

Extracellular vesicles (EVs) are under evaluation as therapeutics or as vehicles for drug delivery. Preclinical studies of EVs often use mice or other animal models to assess efficacy and disposition. However, as most EVs under evaluation are derived from...

Cite
Zhu X, Badawi M, Pomeroy S, et al. Comprehensive toxicity and immunogenicity studies reveal minimal effects in mice following sustained dosing of extracellular vesicles derived from HEK293T cells. J Extracell Vesicles. 2017;6(1):1324730doi: 10.1080/20013078.2017.1324730.
Zhu, X., Badawi, M., Pomeroy, S., Sutaria, D. S., Xie, Z., Baek, A., Jiang, J., Elgamal, O. A., Mo, X., Perle, K., Chalmers, J., Schmittgen, T. D., & Phelps, M. A. (2017). Comprehensive toxicity and immunogenicity studies reveal minimal effects in mice following sustained dosing of extracellular vesicles derived from HEK293T cells. Journal of extracellular vesicles, 6(1), 1324730. https://doi.org/10.1080/20013078.2017.1324730
Zhu, Xiaohua, et al. "Comprehensive toxicity and immunogenicity studies reveal minimal effects in mice following sustained dosing of extracellular vesicles derived from HEK293T cells." Journal of extracellular vesicles vol. 6,1 (2017): 1324730. doi: https://doi.org/10.1080/20013078.2017.1324730
Zhu X, Badawi M, Pomeroy S, Sutaria DS, Xie Z, Baek A, Jiang J, Elgamal OA, Mo X, Perle K, Chalmers J, Schmittgen TD, Phelps MA. Comprehensive toxicity and immunogenicity studies reveal minimal effects in mice following sustained dosing of extracellular vesicles derived from HEK293T cells. J Extracell Vesicles. 2017 Jun 06;6(1):1324730. doi: 10.1080/20013078.2017.1324730. eCollection 2017. PMID: 28717420; PMCID: PMC5505007.
Copy Download .nbib Format: NLM
Validation of Low-Cost Sensors in Measuring Real-Time PM.

Sensors (Basel, Switzerland)

Sahu R, Dixit KK, Mishra S, Kumar P, Shukla AK, Sutaria R, Tiwari S, Tripathi SN.
PMID: 32121462
Sensors (Basel). 2020 Feb 29;20(5). doi: 10.3390/s20051347.

In the present study, we assessed for the first time the performance of our custom-designed low-cost Particulate Matter (PM) monitoring devices (Atmos) in measuring PM

Cite
Sahu R, Dixit KK, Mishra S, et al. Validation of Low-Cost Sensors in Measuring Real-Time PM. Sensors (Basel). 2020;20(5)doi: 10.3390/s20051347.
Sahu, R., Dixit, K. K., Mishra, S., Kumar, P., Shukla, A. K., Sutaria, R., Tiwari, S., & Tripathi, S. N. (2020). Validation of Low-Cost Sensors in Measuring Real-Time PM. Sensors (Basel, Switzerland), 20(5), . https://doi.org/10.3390/s20051347
Sahu, Ravi, et al. "Validation of Low-Cost Sensors in Measuring Real-Time PM." Sensors (Basel, Switzerland) vol. 20,5 (2020). doi: https://doi.org/10.3390/s20051347
Sahu R, Dixit KK, Mishra S, Kumar P, Shukla AK, Sutaria R, Tiwari S, Tripathi SN. Validation of Low-Cost Sensors in Measuring Real-Time PM. Sensors (Basel). 2020 Feb 29;20(5). doi: 10.3390/s20051347. PMID: 32121462; PMCID: PMC7085545.
Copy Download .nbib Format: NLM
Influence of occlusal vertical dimension on lip positions at smile in completely dentulous adults.

Journal of Indian Prosthodontic Society

Parmar DR, Mehta SP, Sutariya PV, Bhatia YA, Gupta NK.
PMID: 32089601
J Indian Prosthodont Soc. 2020 Jan-Mar;20(1):69-75. doi: 10.4103/jips.jips_239_19. Epub 2020 Jan 27.

MATERIALS AND METHODS: Thirty individuals aged between 22 and 30 years were selected for the study. Poly-vinyl siloxane (Jet Bite, Coltene, Switzerland) interocclusal bite records of varying thickness of +1, +2, +3, and +4 mm were made using articulated...

Cite
Parmar DR, Mehta SP, Sutariya PV, et al. Influence of occlusal vertical dimension on lip positions at smile in completely dentulous adults. J Indian Prosthodont Soc. 2020;20(1):69-75doi: 10.4103/jips.jips_239_19.
Parmar, D. R., Mehta, S. P., Sutariya, P. V., Bhatia, Y. A., & Gupta, N. K. (2020). Influence of occlusal vertical dimension on lip positions at smile in completely dentulous adults. Journal of Indian Prosthodontic Society, 20(1), 69-75. https://doi.org/10.4103/jips.jips_239_19
Parmar, Dharti Rajubhai, et al. "Influence of occlusal vertical dimension on lip positions at smile in completely dentulous adults." Journal of Indian Prosthodontic Society vol. 20,1 (2020): 69-75. doi: https://doi.org/10.4103/jips.jips_239_19
Parmar DR, Mehta SP, Sutariya PV, Bhatia YA, Gupta NK. Influence of occlusal vertical dimension on lip positions at smile in completely dentulous adults. J Indian Prosthodont Soc. 2020 Jan-Mar;20(1):69-75. doi: 10.4103/jips.jips_239_19. Epub 2020 Jan 27. PMID: 32089601; PMCID: PMC7008624.
Copy Download .nbib Format: NLM
Novel Population Pharmacokinetic Approach to Explain the Differences between Cystic Fibrosis Patients and Healthy Volunteers via Protein Binding.

Pharmaceutics

Shah NR, Bulitta JB, Kinzig M, Landersdorfer CB, Jiao Y, Sutaria DS, Tao X, Höhl R, Holzgrabe U, Kees F, Stephan U, Sörgel F.
PMID: 31216743
Pharmaceutics. 2019 Jun 18;11(6). doi: 10.3390/pharmaceutics11060286.

The pharmacokinetics in patients with cystic fibrosis (CF) has long been thought to differ considerably from that in healthy volunteers. For highly protein bound β-lactams, profound pharmacokinetic differences were observed between comparatively morbid patients with CF and healthy volunteers....

Cite
Shah NR, Bulitta JB, Kinzig M, et al. Novel Population Pharmacokinetic Approach to Explain the Differences between Cystic Fibrosis Patients and Healthy Volunteers via Protein Binding. Pharmaceutics. 2019;11(6)doi: 10.3390/pharmaceutics11060286.
Shah, N. R., Bulitta, J. B., Kinzig, M., Landersdorfer, C. B., Jiao, Y., Sutaria, D. S., Tao, X., Höhl, R., Holzgrabe, U., Kees, F., Stephan, U., & Sörgel, F. (2019). Novel Population Pharmacokinetic Approach to Explain the Differences between Cystic Fibrosis Patients and Healthy Volunteers via Protein Binding. Pharmaceutics, 11(6), . https://doi.org/10.3390/pharmaceutics11060286
Shah, Nirav R, et al. "Novel Population Pharmacokinetic Approach to Explain the Differences between Cystic Fibrosis Patients and Healthy Volunteers via Protein Binding." Pharmaceutics vol. 11,6 (2019). doi: https://doi.org/10.3390/pharmaceutics11060286
Shah NR, Bulitta JB, Kinzig M, Landersdorfer CB, Jiao Y, Sutaria DS, Tao X, Höhl R, Holzgrabe U, Kees F, Stephan U, Sörgel F. Novel Population Pharmacokinetic Approach to Explain the Differences between Cystic Fibrosis Patients and Healthy Volunteers via Protein Binding. Pharmaceutics. 2019 Jun 18;11(6). doi: 10.3390/pharmaceutics11060286. PMID: 31216743; PMCID: PMC6630667.
Copy Download .nbib Format: NLM
Radial artery pseudoaneurysm: A rare complication after a single arterial puncture for blood-gas analysis.

Indian journal of critical care medicine : peer-reviewed, official publication of Indian Society of Critical Care Medicine

Patel KN, Gandhi SP, Sutariya HC.
PMID: 27829723
Indian J Crit Care Med. 2016 Oct;20(10):622-626. doi: 10.4103/0972-5229.192066.

With a reported incidence of 0.048%, radial artery pseudoaneurysm (PA) is a rare but serious complication of arterial cannulation. We report a case of PA developing after a single puncture of the right radial artery for arterial blood-gas analysis...

Cite
Patel KN, Gandhi SP, Sutariya HC. Radial artery pseudoaneurysm: A rare complication after a single arterial puncture for blood-gas analysis. Indian J Crit Care Med. 2016;20(10):622-626doi: 10.4103/0972-5229.192066.
Patel, K. N., Gandhi, S. P., & Sutariya, H. C. (2016). Radial artery pseudoaneurysm: A rare complication after a single arterial puncture for blood-gas analysis. Indian journal of critical care medicine : peer-reviewed, official publication of Indian Society of Critical Care Medicine, 20(10), 622-626. https://doi.org/10.4103/0972-5229.192066
Patel, Kajal Nitin, et al. "Radial artery pseudoaneurysm: A rare complication after a single arterial puncture for blood-gas analysis." Indian journal of critical care medicine : peer-reviewed, official publication of Indian Society of Critical Care Medicine vol. 20,10 (2016): 622-626. doi: https://doi.org/10.4103/0972-5229.192066
Patel KN, Gandhi SP, Sutariya HC. Radial artery pseudoaneurysm: A rare complication after a single arterial puncture for blood-gas analysis. Indian J Crit Care Med. 2016 Oct;20(10):622-626. doi: 10.4103/0972-5229.192066. PMID: 27829723; PMCID: PMC5073782.
Copy Download .nbib Format: NLM
Magnetic Control of the Manganese Photoluminescence in Fe.

ACS omega

Sutariya S, Bsatee M, Gololobova O, Diaz-Diestra D, Thapa B, Weiner BR, Morell G, Jadwisienczak WM, Beltran-Huarac J.
PMID: 33778270
ACS Omega. 2021 Mar 10;6(11):7598-7604. doi: 10.1021/acsomega.0c06164. eCollection 2021 Mar 23.

We investigated the magnetic control of the Mn photoluminescence (PL) in iron oxide/l-cysteine-capped zinc sulfide (Fe

Cite
Sutariya S, Bsatee M, Gololobova O, et al. Magnetic Control of the Manganese Photoluminescence in Fe. ACS Omega. 2021;6(11):7598-7604doi: 10.1021/acsomega.0c06164.
Sutariya, S., Bsatee, M., Gololobova, O., Diaz-Diestra, D., Thapa, B., Weiner, B. R., Morell, G., Jadwisienczak, W. M., & Beltran-Huarac, J. (2021). Magnetic Control of the Manganese Photoluminescence in Fe. ACS omega, 6(11), 7598-7604. https://doi.org/10.1021/acsomega.0c06164
Sutariya, Shyam, et al. "Magnetic Control of the Manganese Photoluminescence in Fe." ACS omega vol. 6,11 (2021): 7598-7604. doi: https://doi.org/10.1021/acsomega.0c06164
Sutariya S, Bsatee M, Gololobova O, Diaz-Diestra D, Thapa B, Weiner BR, Morell G, Jadwisienczak WM, Beltran-Huarac J. Magnetic Control of the Manganese Photoluminescence in Fe. ACS Omega. 2021 Mar 10;6(11):7598-7604. doi: 10.1021/acsomega.0c06164. eCollection 2021 Mar 23. PMID: 33778270; PMCID: PMC7992155.
Copy Download .nbib Format: NLM
GADD45α-targeted suicide gene therapy driven by synthetic CArG promoter E9NS sensitizes NSCLC cells to cisplatin, resveratrol, and radiation regardless of p53 status.

OncoTargets and therapy

Shi Q, Sutariya V, Varghese Gupta S, Bhatia D.
PMID: 31114253
Onco Targets Ther. 2019 Apr 26;12:3161-3170. doi: 10.2147/OTT.S192061. eCollection 2019.

No abstract available.

Cite
Shi Q, Sutariya V, Varghese Gupta S, et al. GADD45α-targeted suicide gene therapy driven by synthetic CArG promoter E9NS sensitizes NSCLC cells to cisplatin, resveratrol, and radiation regardless of p53 status. Onco Targets Ther. 2019;12:3161-3170doi: 10.2147/OTT.S192061.
Shi, Q., Sutariya, V., Varghese Gupta, S., & Bhatia, D. (2019). GADD45α-targeted suicide gene therapy driven by synthetic CArG promoter E9NS sensitizes NSCLC cells to cisplatin, resveratrol, and radiation regardless of p53 status. OncoTargets and therapy, 123161-3170. https://doi.org/10.2147/OTT.S192061
Shi, Qiwen, et al. "GADD45α-targeted suicide gene therapy driven by synthetic CArG promoter E9NS sensitizes NSCLC cells to cisplatin, resveratrol, and radiation regardless of p53 status." OncoTargets and therapy vol. 12 (2019): 3161-3170. doi: https://doi.org/10.2147/OTT.S192061
Shi Q, Sutariya V, Varghese Gupta S, Bhatia D. GADD45α-targeted suicide gene therapy driven by synthetic CArG promoter E9NS sensitizes NSCLC cells to cisplatin, resveratrol, and radiation regardless of p53 status. Onco Targets Ther. 2019 Apr 26;12:3161-3170. doi: 10.2147/OTT.S192061. eCollection 2019. PMID: 31114253; PMCID: PMC6497884.
Copy Download .nbib Format: NLM
Autoimmune myositis and myasthenia gravis resulting from a combination therapy with nivolumab and ipilimumab for metastatic melanoma.

European journal of rheumatology

Sutaria R, Patel P, Danve A.
PMID: 30986169
Eur J Rheumatol. 2019 Apr 09;6(3):153-154. doi: 10.5152/eurjrheum.2019.18159. Print 2019 Jul.

Checkpoint inhibitors are a novel option in the management of metastatic melanomas and many other malignancies. They are used to promote the activation of cytotoxic T-lymphocytes by inhibiting deactivation signals, enabling the immune response to the tumor. Numerous Immune-related...

Cite
Sutaria R, Patel P, Danve A. Autoimmune myositis and myasthenia gravis resulting from a combination therapy with nivolumab and ipilimumab for metastatic melanoma. Eur J Rheumatol. 2019;6(3):153-154doi: 10.5152/eurjrheum.2019.18159.
Sutaria, R., Patel, P., & Danve, A. (2019). Autoimmune myositis and myasthenia gravis resulting from a combination therapy with nivolumab and ipilimumab for metastatic melanoma. European journal of rheumatology, 6(3), 153-154. https://doi.org/10.5152/eurjrheum.2019.18159
Sutaria, Ravi, et al. "Autoimmune myositis and myasthenia gravis resulting from a combination therapy with nivolumab and ipilimumab for metastatic melanoma." European journal of rheumatology vol. 6,3 (2019): 153-154. doi: https://doi.org/10.5152/eurjrheum.2019.18159
Sutaria R, Patel P, Danve A. Autoimmune myositis and myasthenia gravis resulting from a combination therapy with nivolumab and ipilimumab for metastatic melanoma. Eur J Rheumatol. 2019 Apr 09;6(3):153-154. doi: 10.5152/eurjrheum.2019.18159. Print 2019 Jul. PMID: 30986169; PMCID: PMC6668642.
Copy Download .nbib Format: NLM
Immunohistochemical evaluation of p63 and cyclin D1 in oral squamous cell carcinoma and leukoplakia.

Journal of the Korean Association of Oral and Maxillofacial Surgeons

Patel SB, Manjunatha BS, Shah V, Soni N, Sutariya R.
PMID: 29142867
J Korean Assoc Oral Maxillofac Surg. 2017 Oct;43(5):324-330. doi: 10.5125/jkaoms.2017.43.5.324. Epub 2017 Oct 26.

OBJECTIVES: There are only a limited number of studies on cyclin D1 and p63 expression in oral squamous cell carcinoma (OSCC) and leukoplakia. This study compared cyclin D1 and p63 expression in leukoplakia and OSCC to investigate the possible...

Cite
Patel SB, Manjunatha BS, Shah V, et al. Immunohistochemical evaluation of p63 and cyclin D1 in oral squamous cell carcinoma and leukoplakia. J Korean Assoc Oral Maxillofac Surg. 2017;43(5):324-330doi: 10.5125/jkaoms.2017.43.5.324.
Patel, S. B., Manjunatha, B. S., Shah, V., Soni, N., & Sutariya, R. (2017). Immunohistochemical evaluation of p63 and cyclin D1 in oral squamous cell carcinoma and leukoplakia. Journal of the Korean Association of Oral and Maxillofacial Surgeons, 43(5), 324-330. https://doi.org/10.5125/jkaoms.2017.43.5.324
Patel, Sunit B, et al. "Immunohistochemical evaluation of p63 and cyclin D1 in oral squamous cell carcinoma and leukoplakia." Journal of the Korean Association of Oral and Maxillofacial Surgeons vol. 43,5 (2017): 324-330. doi: https://doi.org/10.5125/jkaoms.2017.43.5.324
Patel SB, Manjunatha BS, Shah V, Soni N, Sutariya R. Immunohistochemical evaluation of p63 and cyclin D1 in oral squamous cell carcinoma and leukoplakia. J Korean Assoc Oral Maxillofac Surg. 2017 Oct;43(5):324-330. doi: 10.5125/jkaoms.2017.43.5.324. Epub 2017 Oct 26. PMID: 29142867; PMCID: PMC5685862.
Copy Download .nbib Format: NLM
Showing 1 to 12 of 50 entries